Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides.
Daclatasvir inhibits hepatitis C virus NS5A motility and hyper-accumulation of phosphoinositides. Virology. 2015 Feb; 476:168-179.
View in:
PubMed
subject areas
Antiviral Agents
Carbamates
Cell Line
Hepacivirus
Hepatitis C
Humans
Imidazoles
Minor Histocompatibility Antigens
Phosphatidylinositols
Phosphotransferases (Alcohol Group Acceptor)
Protein Binding
Protein Transport
Pyrrolidines
Valine
Viral Nonstructural Proteins
Virus Replication
authors with profiles
Glenn C. Randall